Top 10 Drugs Q3 2024: Paxlovid Returns As Humira Bows Out
Wegovy Poised To Join List With Fellow GLP-1s Ozempic, Mounjaro
Keytruda, Ozempic and Dupixent were the three best-selling drugs by global revenues in the third quarter. AbbVie’s long-time cash cow Humira finally exited the top 10, slipping to 16th place.
